Formulation and in Vitro Characterization of a Novel Solid Lipid-Based Drug Delivery System
-
- Ma Hongxing
- Clinical Lab of Daqing Oil General Hospital
-
- Chu Mingjuan
- Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University-Daqing
-
- Itagaki Kiyoshi
- Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School
-
- Xin Ping
- Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University-Daqing
-
- Zhou Xuegang
- Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University-Daqing
-
- Zhang Dawei
- College of Life and Environmental Sciences, Harbin Normal University
-
- Wang Youzhi
- Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University-Daqing
-
- Fu Jia
- Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University-Daqing
-
- Sun Shiqin
- Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University-Daqing
書誌事項
- タイトル別名
-
- Formulation and <i>in Vitro</i> Characterization of a Novel Solid Lipid-Based Drug Delivery System
この論文をさがす
抄録
The liquid self-emulsifying drug delivery system (L-SEDDS), commonly used to deliver effective but poorly water-soluble oleanolic acid (OA), has many limitations such as high manufacturing costs, few choices of dosage forms, risk of leakage from hard gelatin capsules, low stability, limited portability, incompatibility with capsule materials, and relatively restricted storage conditions. Thus the main purpose of our study was to develop a promising solid lipid-based drug delivery system (S-SEDDS) for OA. The S-SEDDS, prepared from wet granulation with an optimized L-SEDDS formulation and mannitol, was characterized by particle size analysis, scanning electron microscopy, differential scanning calorimetry, and X-ray powder diffraction. Finally, the solubility of the OA-loaded S-SEDDS was compared with that of OA powder in the dissolution assay. Our new S-SEDDS for OA was developed from the optimum L-SEDDS with ethyl oleate (oil phase), Labrasol (surfactant), and Transcutol P (cosurfactant) at a volume ratio of 15 : 71 : 14 with 1.5% w/v OA and mannitol. The dissolution of OA was improved by 60% compared with that of the pure OA powder. All the problems associated with the L-SEDDS were resolved. The methodologies we developed for OA delivery could also be utilized for the delivery of other drugs with the S-SEDDS.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 62 (12), 1173-1179, 2014
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679153615872
-
- NII論文ID
- 130004712911
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 025935940
-
- PubMed
- 25450625
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可